ArticleBMJ open2025

Abatacept versus tocilizumab for the treatment of rheumatoid arthritis in TNF inhibitor inadequate responders: study protocol of the SUNSTAR randomised controlled open-label superiority trial.

Tristan Pascart et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.